Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2O9B
|
||||
Drug Name |
4-Benzenesulfonylamino-3-chloro-N-[1-(2S-ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-benzamide
|
||||
Synonyms |
CHEMBL474059
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H34ClN3O6S
|
||||
Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)c(Cl)c3
|
||||
InChI |
InChI=1S/C28H34ClN3O6S/c1-3-24-25(23(33)17-38-24)31-27(35)22(16-28(2)13-7-8-14-28)30-26(34)18-11-12-21(20(29)15-18)32-39(36,37)19-9-5-4-6-10-19/h4-6,9-12,15,22,24-25,32H,3,7-8,13-14,16-17H2,1-2H3,(H,30,34)(H,31,35)/t22-,24-,25+/m0/s1
|
||||
InChIKey |
PURTXMAIRNXPDK-ZKMPZPQNSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.